ATNT-11 A PHASE I PHARMACODYNAMIC STUDY OF DISULFIRAM AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA AFTER RADIATION THERAPY AND CONCURRENT TEMOZOLOMIDE

Documenti analoghi

• ACTR-21. UPDATED RESULTS OF A PHASE I DOSE-ESCALATION, DOSE-EXPANSION STUDY OF DISULFIRAM AND ADJUVANT TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
  di: Huang, Jiayi, et al.
  Pubblicazione: (2017)
• IMCT-13 LYMPHOPENIA IN ELDERLY PATIENTS WITH GLIOBLASTOMA TREATED WITH RADIATION AND TEMOZOLOMIDE
  di: Mendez, Joe, et al.
  Pubblicazione: (2015)
• RTRB-22 HYPOFRACTIONATED RADIOTHERAPY VERSUS STANDARD FRACTIONATED RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
  di: Wang, Tony, et al.
  Pubblicazione: (2015)
• ATNT-10 DOES VALPROIC ACID IMPROVE SURVIVAL IN GLIOBLASTOMA? A META-ANALYSIS OF RANDOMIZED TRIALS IN NEWLY DIAGNOSED GLIOBLASTOMA
  di: Happold, Caroline, et al.
  Pubblicazione: (2015)
• Concurrent Temozolomide and Dose-Escalated Intensity Modulated Radiation Therapy in Newly Diagnosed Glioblastoma
  di: Tsien, Christina I., et al.
  Pubblicazione: (2011)